As prostate cancer rates rise, researchers are racing to understand the faulty genes that fuel the disease and find more effective treatments. This task is made tougher by the fact that only a handful of gene faults have been found so far. One new kid on this genetic block is beta-catenin, which is implicated in a number of other cancers. To find out more about beta-catenin's role in normal prostate growth and in cancer, researchers have bred 'knockout' mice lacking the gene. On the left is the developing prostate gland of a mouse just a few days before birth, showing orange-coloured buds that will go on to form fluid-secreting ducts in the adult prostate. These buds haven't properly formed in the gland on the right, taken from a mouse lacking beta-catenin. The scientists have found that beta-catenin is also involved in aggressive prostate cancer, revealing new routes to potential therapies.
Written by Kat Arney
BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.